BaldessariniR. J., TarsyD.: “Tardive dyskinesia.” Presented at the American College of Neuropsychopharmacology Meeting, New Orleans, 1976.
2.
GrattonL.: Neuroleptiques, parkinsonnisme et schizophrénie.Union Méd Canada89: 681–694, 1960.
3.
HackmanE., Wirz-JusticeA., LichsteinerM.: The uptake of dopamine and serotonine in rat brain during progesterone decline.Psychopharmacologia32: 183–191, 1973.
4.
JoriA., DolfiniE.: Modifications of striatal dopamine levels by steroid contraceptive drugs in mice and rats.Neuroen-docrinology21: 74–78, 1976.
5.
KlawansH. L., WeinerW. J.: Attempted use of haloperidol in the treatment of L-Dopa-induced dyskinesias.J Neurol Neurosurg37: 427–430, 1974.
6.
LabrieF., BeaulieuM., CaronM., RaymondV.: “The adenohypophyscal dopamine receptors specificity and modulation of its activity by estradiol.” In: Proc Int Symp on Prolactin, RobynC., and HarterM. Eds., Elsevier/North-Holland Biomedical Press, 1977 (in press).
7.
MarsdenC. D., TarsyD., BaldessariniR. J.: Spontaneous and drug-induced movement disorders in psychotic patients. In: Psychiatric Aspects of Neurologic Disease.BensonD. F., and BlumerD. Eds. Ch. 12, pp. 219–265, New York: Grune and Stratton, Publ., 1975.
8.
PaulS. M., AxelrodJ.: Catechol estrogens: presence in brain and endocrine tissues.Science197: 657–659, 1977.
9.
RaymondV., BeaulieuM., LabrieF., BoissierJ. R.: “Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release.” (Submitted for publication).
10.
TarsyD., ParkesJ. D., MarsdenC. D.: Methoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.J Neurol Neurosurg38: 331–335, 1975.
11.
TarsayD., BaldessariniR. J.: The tardive dyskinesia syndrome. In: Clinical Neuropharmacology, Vol. 1. KlawansH. L. Ed. Ch. 2, pp. 29–61, New York: Raven Press, Publ., 1976.
12.
VilleneuveA., BöszörményiZ.: Treatment of drug-induced dyskinesias, LancetI: 353–354, 1970.
13.
VilleneuveA., BöszörményiZ., DeschambaultM., LachanceR.: Tentative de traitement de la dyskinésie post-neuroleptique de type permanent.Laval Médical41: 923–933, 1970.
14.
VilleneuveA.: “Drug-induced extrapyramidal reactions.” In: Neuro-Psycho-pharmacology, DenikerP., Radouco-ThomasC., and VilleneuveA. Eds., pp. 709–713, Pergamon Press, Oxford1977 (in press).